A Study on Banned Drugs in India: A Review
Kengar Manohar D.*, Jagtap Ganesh B. Vambhurkar Asha M., Gavade Akshata S., Nitalikar Manojkumar M.
Rajarambapu College of Pharmacy, Kasegaon, Dist-Sangli, Maharashtra, India-415404
*Corresponding Author E-mail: firstname.lastname@example.org
Online published on 25 December, 2018.
The numbers of single drugs as well as fixed dose combinations drugs are banned in other countries but they have manufacturing, marketing and distribution in India. Over the counter availability of banned drugs sufficient adverse drug reactions data about these drugs have not been reported. The adverse effect of drugs is detected by regular monitoring after the drug released called pharmacovigilance. The Indian regulatory authority monitoring the new drug in market before pre-clinical study and permit to sold in market. The banned dugs prescribed over the counter the responsible as unawareness of physicians and patients, poverty, self-medication, carelessness of regulatory authorities, non availability of appropriate drugs, high cost, and communication. The Government of India is in the process of developing a regulatory regime designed to ensure the quality, safety and performance of medical devices.
Banned Drug, Indian Drug, FDA, Adverse drug reaction, Pharmacovigilance.